
Fluidigm Corporation FLDM
Fluidigm Corporation Kurzfristige Verbindlichkeiten 2011-2026 | FLDM
Kurzfristige Verbindlichkeiten Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 54.2 M | 32.8 M | 37.6 M | 33.5 M | 29.5 M | 30.1 M | 29.4 M | 18 M | 11.6 M | 20.2 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 54.2 M | 11.6 M | 29.7 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
Danaher Corporation
DHR
|
6.8 B | $ 237.64 | 1.12 % | $ 174 B | ||
|
DarioHealth Corp.
DRIO
|
12.5 M | $ 12.15 | -5.81 % | $ 345 M | ||
|
Burning Rock Biotech Limited
BNR
|
372 M | $ 23.25 | -0.66 % | $ 250 M | ||
|
DexCom
DXCM
|
1.56 B | $ 66.95 | -2.16 % | $ 25.8 B | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
37.3 M | $ 1.59 | -0.94 % | $ 2.02 M | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
5.75 M | $ 6.12 | - | $ 180 M | ||
|
IQVIA Holdings
IQV
|
6.96 B | $ 243.33 | 0.06 % | $ 44.1 B | ||
|
Castle Biosciences
CSTL
|
49.4 M | $ 39.59 | -0.76 % | $ 1.1 B | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
310 M | $ 234.65 | -2.05 % | $ 23.1 B | ||
|
CareDx, Inc
CDNA
|
78.1 M | $ 17.02 | -1.16 % | $ 915 M | ||
|
Celcuity
CELC
|
31.7 M | $ 107.43 | 2.63 % | $ 4.24 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Pacific Biosciences of California
PACB
|
95 M | $ 1.95 | -4.66 % | $ 495 M | ||
|
Anixa Biosciences
ANIX
|
2.5 M | $ 3.41 | -0.29 % | $ 109 K | ||
|
Exact Sciences Corporation
EXAS
|
732 M | $ 102.13 | 0.34 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
72.9 M | $ 27.84 | -0.2 % | $ 842 M | ||
|
QIAGEN N.V.
QGEN
|
544 M | $ 48.32 | -0.27 % | $ 10.8 B | ||
|
RadNet
RDNT
|
480 M | $ 77.42 | -1.22 % | $ 5.65 B | ||
|
Guardant Health
GH
|
226 M | $ 110.18 | 1.32 % | $ 13.5 B | ||
|
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
1.55 B | $ 141.01 | -3.31 % | $ 22.4 B | ||
|
Charles River Laboratories International
CRL
|
994 M | $ 220.64 | 2.38 % | $ 11.3 B | ||
|
Thermo Fisher Scientific
TMO
|
13.3 B | $ 620.69 | 2.34 % | $ 237 B | ||
|
Twist Bioscience Corporation
TWST
|
91.4 M | $ 35.58 | 2.42 % | $ 2.13 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 175.1 | -1.49 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
14.3 M | $ 5.46 | -2.15 % | $ 708 M | ||
|
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 252.61 | -0.81 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 183.13 | -2.7 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
1.07 B | $ 715.47 | 0.43 % | $ 59 B | ||
|
Lantheus Holdings
LNTH
|
241 M | $ 67.98 | 0.19 % | $ 4.7 B | ||
|
Agilent Technologies
A
|
1.71 B | $ 148.92 | 2.17 % | $ 45.3 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.75 | -4.84 % | $ 6.32 M | ||
|
Bioventus
BVS
|
175 M | $ 8.02 | 0.25 % | $ 502 M |